Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2009 Nov 30:450–455. doi: 10.1016/B978-141602299-2.10060-X

Upper Respiratory Tract Infection

May Loo 1,2
PMCID: PMC7151893

Inline graphic PEDIATRIC DIAGNOSIS AND MANAGEMENT

Upper respiratory tract infection (URI), or the common cold, is the most frequent infection in children in the United States and throughout the industrialized world. It is the major cause for visits to pediatrician.1 A preschool-aged child has an average of 6 to 10 colds per year, and 10% to 15% of school-aged children have at least 12 infections per year. The greatest incidence is from early fall until the late spring,2 resulting in frequent absences from school.

The clinical symptoms vary greatly without any correlation with specific viruses.3 The majority of the symptoms are mild, consisting of rhinorrhea, sneezing, nasal congestion and obstruction, postnasal drip, and cough. Additional symptoms of low-grade fever, sore throat, clear eye discharge, digestive discomfort, and general malaise may also be present.4., 5. Some common viruses that cause URI include rhinovirus, coronavirus, adenovirus, respiratory syncytial virus (RSV), influenza, and parainfluenza virus.3., 6., 7. Transmission varies with different viruses. RSV spreads primarily through contact with symptomatic children and contaminated objects; influenza spreads mainly via airborne droplets. The precise route of transmission for rhinovirus remains controversial.6

The viruses gain entry into host cells through specific viral surface proteins, which cause tissue injury and result in clinical disease.8 For example, parainfluenza viruses bind to cell surface receptors and then fuse directly with the cell membrane to release the viral replication machinery into the host cell's cytoplasm.9 Recent studies suggest that it is the host's response to the virus, not the virus itself, that determines the pathogenesis and severity of common cold. Proinflammatory mediators, especially the cytokines, appear to be the central component of the response by infected cells.10., 11., 12.

The virulence of rhinovirus is strongest in infants younger than 1 year (median age 6.5 months)13 and in immunocompromised children.14 Wheezing is associated with RSV in children younger than 2 years and with rhinovirus in those older than 2 years.15 Influenza has an annual attack rate between 15% and 42% in preschool- and school-aged children.16., 17.

Simultaneous infection by more than one virus, such as RSV and adenovirus together, can also occur frequently in the pediatric population.13 Many children can also have associated bacterial infection, such as Haemophilus influenzae conjunctivitis.13

Specific viral diagnosis is not necessary, both because of the benign, self-limiting nature of the disease18 and also because the prevalence of different viruses overlaps from fall to spring, such that it is very difficult to determine precisely which virus or viruses are causing the symptoms.3 Current medical management of URI remains symptomatic, controversial, and in most cases ineffective. Fluid, rest, humidifier, and saline nose drops constitute the mainstay of nonpharmacological treatment. The role of vitamin C both in prevention and in treatment of the common cold remains controversial.19., 20. Topical adrenergic agents do not have systemic side effects, but overuse can result in rebound congestion.21

Systemic medications are primarily used for symptomatic relief of congestion and cough, and most have limited efficacy.11 Antihistamine and combinations of antihistamine with decongestants are the ingredients in at least 800 over-the-counter (OTC) cold remedies. The majority of studies in the past decade,5., 21., 22., 23. as well as recent meta-analyses, continue to conclude that antihistamines and OTC medicines are of marginal or no benefit in treating cold symptoms.24., 25., 26. First-generation antihistamines can cause untoward side effects such as sedation in children.26 Dextromethorphan is an antitussive that is abundant in OTC formulations. Although this medication is reportedly safe when taken in the recommended dosages, cases of recreational use by teenagers and deaths by overdose have been reported.27 A 2007 study, which was based on a report by the Centers for Disease Control and Prevention (CDC), reported that three infants died from the toxic effects of cough and cold medicines in 2005, and more than 1500 children younger than 2 years were treated in emergency departments for adverse events related to cough and cold medicines in 2004 and 2005.27a As a result, the U.S. Food and Drug Administration issued a statement recommending cough and cold products not be given to children younger than 2 years unless directed by a healthcare provider.

Codeine is ineffective in controlling URI cough.28 Antibiotics are never indicated for the common cold5., 29., 30. but continue to be injudiciously overprescribed, leading to the emergence of more resistant strains of bacteria, higher healthcare costs, and increased risk of side effects.31., 32., 33., 34., 35., 36, 37. During the influenza season, the number of antimicrobial courses prescribed to children increases by 10% to 30%.17

Research for new medical therapies for the common cold is directed toward increasing resistance to or immunity against the viruses. Interferons are proteins that can induce a nonspecific resistance to viral infection. However, the usual route of administration is by intramuscular injection, usually given on a daily basis because its blood concentration decreases sharply within 24 hours. In view of the self-limiting nature of URI and the trauma of daily injections, it is unlikely that interferon would be used to treat URI in children.38 Histamine antagonists are not indicated in the common cold.39 Antiinflammatory mediators11 and specific antiviral agents40 may be promising. Although viral URI is a benign illness of short duration, it can lead to bacterial complications—otitis media, sinusitis and lower respiratory tract infections, or even mastoiditis and meningitis—that have much more significant consequences in children.41., 42. Younger infants are especially susceptible to development of more serious bacterial infections.

The best treatment is prevention. Parents and family members should be educated about washing hands, cleaning environmental surfaces, isolating infants and children with infection, and avoiding crowded places such as busy daycare centers.22 The American Academy of Pediatrics (AAP) recommends that RSV intravenous immune globulin (RSV-IGIV) and palivizumab, a humanized murine monoclonal antibody, be administered as prophylaxis for prevention of RSV URI, which can lead to severe lower respiratory tract infections in high-risk infants, children younger than 24 months with chronic lung disease, certain preterm infants, and children with congenital heart disease.43 The CDC has marked vaccine development for RSV “a high priority.”44 The AAP also recommends annual influenza immunization for all children with high-risk conditions who are 6 months of age and older, healthy children 6 through 24 months of age, household contacts and out-of-home caregivers of children younger than 24 months of age, and healthcare professionals.45 The World Health Organization is attempting to develop and distribute effective vaccines to prevent and/or reduce key viral respiratory diseases.46

Development of one single vaccine effective against the common cold is unlikely because of the large number of viral serotypes.4 Rhinovirus, for example, has at least 100 different immunotypes.12 The goals of a vaccination program for viral URI are the prevention of lower respiratory tract infections and the prevention of infection-associated morbidities, hospitalization, and mortality.

Inline graphic CAM THERAPY RECOMMENDATIONS

Acupuncture

Traditional Chinese medicine (TCM) defines URI as Wind-Cold, which is similar to but a different description of the Western concept of virus infection as the external cold pathogen transmitted via wind or airborne droplets. Along with symptomatic treatment and home management, TCM also focuses simultaneously on “eliminating the pathogenic factors by supporting the healthy energy,”1 which translates in biochemical terms as improving the immunity and general health of the child. This is especially important in URI because the host response is of primary importance in pathogenesis of URI and because recurrent URIs are more likely to lead to complications. Because URI, like asthma, is seasonal, TCM often adopts the tenet of “winter disease, summer cure,” advocating the stimulation of pertinent acupoints, such as Wind points, during the summer to prevent URI occurrence during cold weather.2

Current reports support efficacy of acupuncture for treating the common cold.3., 4., 5., 6. URI occurs at the most superficial stage of Wind-Cold invasion. Treatment of BL points can be beneficial even in infants.7 Symptomatic improvement can be substantiated by positive physiological changes. Acupuncture stimulation of LI20 and LI4 has been shown to increase the velocity of the nasal mucociliary transport in chronic rhinitis patients4; a pilot study showed change in nasal airway resistance, although the results were not statistically significant.8

Although there is a paucity of studies on acupuncture treatment of URI in children, as these children are usually kept at home for observation, results from studies of lower respiratory tract infection, allergic rhinitis, and adult studies can be extrapolated for URI in improvement of immune function and alleviation of symptoms. A clinical report using herbal paste to stimulate acupuncture points in 72 infants with acute bronchitis demonstrated high clinical cure and improvement rate, while laboratory findings revealed an increase in humoral immune substances such as immunoglobulin (Ig)-M, IgG, complement C3, and especially IgA.9 A double-blind, randomized, placebo-controlled trial from Hong Kong of 85 children treated for persistent allergic rhinitis demonstrated acupuncture as being effective in decreasing acute symptoms and increasing the symptom-free days with no serious adverse effects.10 Needling general Wind-Cold points in adults—Dazhui (GV14), Fengchi (GB20), and Quchi (LI11)—resulted in decrease in temperature, respiratory rate, pulse, and blood pressure with a simultaneous increase in the percentage of T-lymphocytes.11 Even massaging local acupoints was effective in relieving symptoms and enhancing immune functions, with increases in immune indices that persisted for at least 6 months.1 One report of acumassage of Yingxiang LI20 for only 30 seconds resulted in clinical relief from nasal congestion, even though no change in nasal airway resistance or airflow occurred.12 These reports are encouraging for parents, as acupressure can be easily learned by nonprofessionals; is well tolerated by children of all ages, including infants; has no side effects; and costs nothing.

Acupuncture can be used to treat URI complications such as otitis media or sinusitis. In a clinical study of chronic maxillary sinusitis that included children as young as 3 years, acupuncture treatment resulted in significant improvement of symptoms. However, because of the danger of rapid progression to more serious sequelae, the author recommends that antibiotics still be considered for acute sinusitis.13

Treatment

Acupuncture treatment protocol for URI is as follows14:

  • Increase fluid intake.

  • Decrease Cold energy foods.

  • General treatment to Dispel Wind—major points BL12, GB20.

  • Local points for rhinitis: LI20, Yintang, ST2:
    • Connect with ion pumping cord: black on LI20 or ST2; red on distal point BL60.
  • If using magnets, place bionorth (–) pole facing down on LI20 or ST2 and biosouth (+) pole facing down on BL60, and connect with ion pumping cord as previously described.

  • Use the Five-Element, Four-Point Cold treatment to eliminate Cold from the Bladder channel:
    • Tonify BL60, SI5; sedate BL66.
  • ST40 to transform Phlegm.

  • GV14, LI11 to clear Heat if fever is present.

  • Tonify immune system.

  • Home massage program:
    • Teach parents to massage LI20 for symptomatic relief.
    • Massage BL meridian for general tonification and improvement of immunity.

Aromatherapy

URI occurs commonly in children. The aromatherapy approach is twofold, using essential oils as preventatives and as treatment for an existing condition. To prevent URI, antiseptic essentials oils can be diffused into common spaces or bedrooms to decrease airborne microorganisms. An effective way to do this is to make a disinfectant room spray. Kelville and Green recommend this mixture: 3 drops eucalyptus (Eucalyptus sp.), 1 drop peppermint (Mentha piperita), 2 drops pine (Pinus sylvestris), 1 drop tea tree (Melaleuca alternifolia), and 2 drops bergamot (Citrus bergamia) in 1 ounce of water.1 This should be shaken just before spraying, as the essential oils tend to separate from the water.

Once a child has an URI, essential oils can play a role in reducing symptoms and shortening the course of the illness. Essential oils can continue to be defused in the room, administered by steam inhalation or applied as a chest rub in which case the essentials oils will be both absorbed and inhaled. Essential oils that are antiviral include thyme (Thymus vulgaris), rosemary (Rosmarinus officinalis), peppermint (M. piperita), ravensare (Ravensara aromatica), tea tree (M. alternifolia), eucalyptus (Eucalyptus sp.), and bergamot (C. bergamia).1., 2., 3. Price and Parr suggest a mixture of 4 drops tea tree, 2 drops lemon (Citrus limon), and 2 drops rose otto (Rosa damascena) in 50 mL carrier oil for a cold.4 They also suggest a mixture of 3 drops sandalwood (Santalum album), 2 drops sweet marjoram (Origanum majorana), and 2 drops sweet thyme in 50 mL carrier oil if the child has a cough.4

A mixture of aromatic oils, camphor, menthol, and eucalyptus in a petroleum base, (Vick's VapoRub, Proctor & Gamble, Cincinnati, Ohio) was studied in a randomized, single-blind, placebo-controlled, crossover design study of 12 adult subjects with chronic bronchitis. In this study, 7.5 grams of the product were inuncted or rubbed on the chest and then covered with a cloth, and the control was the petroleum ointment without aromatic oils. Subjects were randomly assigned to groups and crossed over to the other treatment at a subsequent appointment. There was a significantly enhanced clearance of mucus at 30 minutes and 60 minutes in subjects exposed to the active substance, with no difference during the subsequent 5 hours.5

Herbs—Chinese

Windbreaker is a formula of 21 herbs (Chinese Modular Solutions) designed to clear Wind, Heat, and Phlegm, treating the acute inflammatory stage of colds as well as lingering congestion. The formula is available as a liquid alcohol extract. The alcohol can be removed by placing the drops in a small amount of hot water and allowing it to cool before administration. The dose is 1 dropperful every 3 hours in babies and 2 to 3 droppersful for children 2 years and older (see Appendix C).1

Herbs—Western

Echinacea, a member of the Asteraceae/Compositae family, may be found or used in a variety of species, including Echinacea angustifolia, Echinacea purpurea, and Echinacea pallida.

Taking echinacea orally might help reduce severity of symptoms and duration of the common cold in adults by about 10% to 30%1., 2., 3., 4., 5., 6., 7., 8., 9. or may show no benefit, according to results of other trials.10., 11., 12. Research conducted with E. purpurea juice extract in children aged 2 to 11 years suggested lack of effectiveness for the treatment of cold symptoms.13 In this study, E. purpurea 3.75 mL or 5 mL was taken twice daily based on age. Children in the treatment group were more likely to develop a rash than children taking placebo.13 The best time to take echinacea is not prophylactically, but rather at the initial stages of symptoms, continuing the therapy for 7 to 10 days. Some common side effects reported with the use of echinacea include allergic reactions and gastrointestinal symptoms.

A combination of echinacea, propolis, and vitamin C—an herbal preparation (Chizukit) containing 50 mg/mL echinacea, 50 mg/mL propolis, and 10 mg/mL vitamin C—has been reported to reduce the number and duration of cold episodes in children.14 Unfortunately, overall prevention research has not been well designed; therefore additional research must be conducted before making conclusions and clear recommendations.

Massage Therapy

In 1998, Children's Hospital Boston established the Center for Holistic Pediatric Education and Research (CHPER) to provide complementary and alternative medicine (CAM) consultations and education to inpatients at this hospital. Between 1999 and 2004, 762 consults were provided to patients on the Pulmonary Service; the chief complaints initiating the consultation were pain in the back, upper body, chest, and neck as well as anxiety. During acute or chronic respiratory infections, chest, shoulder, neck, and back discomfort may develop from persistent cough.1., 2., 3. This pain or discomfort could lead to ineffective cough and deep breathing as a result of splinting.1., 2., 3. To help decrease the musculoskeletal pain associated with coughing, children experiencing respiratory infections could benefit from back, shoulder, and anterior chest wall massage therapy with particular attention to the intercostals, scalenes, serratus, pectorals, and trapezius. Should cough-related pain or discomfort extend to the abdomen, massage to the intercostals and external obliques may also be helpful. If children are splinting with cough or laughter or indicating it hurts too much to laugh, this would be a good indication to try some massage to improve their comfort level. Children experiencing respiratory illness may feel more comfortable in an upright position during treatment rather than lying down. To treat the child in an upright position, he or she can be positioned in a chair with the head supported by a table-top pillow or seated upright in the parent's lap with the head resting on the parent's chest or shoulder. Infants and young children can readily be treated while cradled on their parent's shoulder or chest.

In addition to massage being helpful for cough-related pain, massage can also help relax or calm the child or infant who may be experiencing increased work of breathing or intermittent bronchospasms due to illness. Controlled studies have demonstrated decreased anxiety levels in children with asthma or cystic fibrosis who receive parental Swedish massage.4., 5. These studies have also demonstrated increased peak flow readings and improved pulmonary function tests in the massage-treated children compared with controls. Small studies in adult populations with pulmonary disease have also demonstrated improved peak flows6., 7. as well as decreased respiratory rate and increased chest wall expansion.7

Chest physiotherapy (CPT), which incorporates percussion and vibration, originated from use of massage in postoperative patients in the seventeenth century.8 CPT has become a standard of care in hospital settings to prevent and treat atelectasis, ineffective cough, and respiratory secretion management.

References

Pediatric Diagnosis and Management

  • 1.Pitrez P.M., Pitrez J.L. Acute upper respiratory tract infections: outpatient diagnosis and treatment [in Portuguese] J Pediatr (Rio J) 2003;79(Suppl 1):S77–S86. doi: 10.2223/jped.1002. [DOI] [PubMed] [Google Scholar]
  • 2.Behrman R.E., Kliegman R.M., Jenson H.B. Nelson textbook of pediatrics. ed 17. Saunders; Philadelphia: 2004. [Google Scholar]
  • 3.Freymuth F., Vabret A., Gouarin S. Epidemiology of respiratory virus infections [in French] Allergy Immunol (Paris) 2001;33:66–69. abstract. [PubMed] [Google Scholar]
  • 4.Kirkpatrick G.L. The common cold. Primary Care. 1996;23:657–675. doi: 10.1016/S0095-4543(05)70355-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Middleton D.B. An approach to pediatric upper respiratory infections. Am Fam Physician. 1991;44(5 Suppl):33S–40S. 46S-47S. [PubMed] [Google Scholar]
  • 6.Goldmann D.A. Transmission of viral respiratory infections in the home. Pediatr Infect Dis J. 2000;19(10 Suppl):S97–S102. doi: 10.1097/00006454-200010001-00002. [DOI] [PubMed] [Google Scholar]
  • 7.El-Sahly H.M., Atmar R.L., Glezen W.P. Spectrum of clinical illness in hospitalized patients with “common cold” virus infections. Clin Infect Dis. 2000;31:96–100. doi: 10.1086/313937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Walker T.A., Khurana S., Tilden S.J. Viral respiratory infections. Pediatr Clin North Am. 1994;41:1365–1381. doi: 10.1016/s0031-3955(16)38876-9. [DOI] [PubMed] [Google Scholar]
  • 9.Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest. 2005;115:1688–1698. doi: 10.1172/JCI25669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Stickler G.B., Smith T.F., Broughton D.D. The common cold. Eur J Pediatr. 1985;144:4–8. doi: 10.1007/BF00491915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Turner R.B. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol. 1997;78:531–539. doi: 10.1016/S1081-1206(10)63213-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hendley J.O. Clinical virology of rhinoviruses. Adv Virus Res. 1999;54:453–466. doi: 10.1016/S0065-3527(08)60375-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pierres-Surer N., Beby-Defaux A., Bourgoin A. Rhinovirus infections in hospitalized children: a 3-year study [in French] Arch Pediatr. 1998;5:9–14. doi: 10.1016/S0929-693X(97)83459-8. abstract. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pitkaranta A., Hayden F.G. Rhinoviruses: important respiratory pathogens. Ann Med. 1998;30:529–537. doi: 10.3109/07853899709002600. [DOI] [PubMed] [Google Scholar]
  • 15.Rakes G.P., Arruda E., Ingram J.M. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care: IgE and eosinophil analyses. Am J Resp Crit Care Med. 1999;159:785–790. doi: 10.1164/ajrccm.159.3.9801052. [DOI] [PubMed] [Google Scholar]
  • 16.Glezen W.P., Couch R.B. Interpandemic influenza in the Houston area, 1974–76. N Engl J Med. 1978;298:587–592. doi: 10.1056/NEJM197803162981103. [DOI] [PubMed] [Google Scholar]
  • 17.Neuzil K.M., Zhu Y., Griffin M.R. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002;185:147–152. doi: 10.1086/338363. [DOI] [PubMed] [Google Scholar]
  • 18.Nahmias A., Yolken R., Keyserling H. Rapid diagnosis of viral infections: a new challenge for the pediatrician. Adv Pediatr. 1984;32:507–525. [Google Scholar]
  • 19.Kasa R.M. Vitamin C: from scurvy to the common cold. Am J Med Tech. 1983;49:23–26. [PubMed] [Google Scholar]
  • 20.Hemila H. Vitamin C supplementation and common cold symptoms: problems with inaccurate reviews. Nutrition. 1996;12:804–809. doi: 10.1016/s0899-9007(96)00223-7. [DOI] [PubMed] [Google Scholar]
  • 21.Fireman P. Pathophysiology and pharmacotherapy of common upper respiratory diseases. Pharmacotherapy. 1993;13(101S):143S. [PubMed] [Google Scholar]
  • 22.Luks D., Anderson M.R. Antihistamines and the common cold: a review and critique of the literature. J Gen Intern Med. 1996;11:240–244. doi: 10.1007/BF02642483. [DOI] [PubMed] [Google Scholar]
  • 23.Smith M.B., Feldman W. Over the counter cold medications: a critical review of clinical trials between 1950 and 1991. J Am Med Assoc. 1993;269:2258. doi: 10.1001/jama.269.17.2258. [DOI] [PubMed] [Google Scholar]
  • 24.Schroeder K., Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev (4) 2004 doi: 10.1002/14651858.CD001831.pub2. CD001831. [DOI] [PubMed] [Google Scholar]
  • 25.Schroeder K., Fahey T. Should we advise parents to administer over the counter cough medicines for acute cough? Systematic review of randomised controlled trials. Arch Dis Child. 2002;86:170–175. doi: 10.1136/adc.86.3.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sutter A.I., Lemiengre M., Campbell H. Antihistamines for the common cold. Cochrane Database Syst Rev (3) 2003 doi: 10.1002/14651858.CD001267. CD001267. [DOI] [PubMed] [Google Scholar]
  • 27.Murray S., Brewerton T. Abuse of over-the-counter dextromethorphan by teenagers. South Med J. 1993;86:1151–1153. doi: 10.1097/00007611-199310000-00014. [DOI] [PubMed] [Google Scholar]
  • Traynor K. Nonprescription cold remedies unsafe for children, FDA advisers say. Am J Health Syst Pharm. 2007;64:2408–2410. doi: 10.2146/news07070098. [DOI] [PubMed] [Google Scholar]
  • 28.Eccles R. Codeine, cough and upper respiratory infection. Pulmon Pharmacol. 1996;9:293–297. doi: 10.1006/pulp.1996.0038. [DOI] [PubMed] [Google Scholar]
  • 29.Dowell S.F., Schwartz B., Phillips W.R. Appropriate use of antibiotics for URIs in children: part I. Otitis media and acute sinusitis. The Pediatric URI Consensus Team. Am Fam Physician. 1998;58:1113–1118. 1123. [PubMed] [Google Scholar]
  • 30.Dowell S.F., Schwartz B., Phillips W.R. Appropriate use of antibiotics for URIs in children: part II. Cough, pharyngitis and the common cold. The Pediatric URI Consensus Team. Am Fam Physician. 1998;58:1335–1342. 1345. [PubMed] [Google Scholar]
  • 31.Mainous A.G., III, Hueston W.J., Clark J.R. Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold? J Fam Practice. 1996;42:357. [PubMed] [Google Scholar]
  • 32.English J.A., Bauman K.A. Evidence-based management of upper respiratory infection in a family practice teaching clinic. Fam Med. 1997;29:38. [PubMed] [Google Scholar]
  • 33.Nambiar S., Schwartz R.H., Sheridan M.J. Are pediatricians adhering to principles of judicious antibiotic use for upper respiratory tract infections? South Med J. 2002;95:1163–1167. [PubMed] [Google Scholar]
  • 34.Gonzales R., Malone D.C., Maselli J.H. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001;33:757–762. doi: 10.1086/322627. [DOI] [PubMed] [Google Scholar]
  • 35.Gaur A.H., Hare M.E., Shorr R.I. Provider and practice characteristics associated with antibiotic use in children with presumed viral respiratory tract infection. Pediatrics. 2005;115:635–642. doi: 10.1542/peds.2004-0670. [DOI] [PubMed] [Google Scholar]
  • 36.Jelinski S., Parfrey P., Hutchinson J. Antibiotic utilisation in community practices: guideline concurrence and prescription necessity. Pharmacoepidemiol Drug Saf. 2005;14:319–326. doi: 10.1002/pds.1007. [DOI] [PubMed] [Google Scholar]
  • 37.Fakih M.G., Hilu R.C., Savoy-Moore R.T. Do resident physicians use antibiotics appropriately in treating upper respiratory infections? A survey of 11 programs. Clin Infect Dis. 2003;37:853–856. doi: 10.1086/377503. Epub 2003 Aug 27. [DOI] [PubMed] [Google Scholar]
  • 38.Houglum J.E. Interferon: mechanisms of action and clinical value. Clin Pharmacol. 1983;2:20–28. [PubMed] [Google Scholar]
  • 39.Seidenberg J. Antihistamines in pediatrics [in German] Monatsschr Kinderheilkd. 1989;137:54–56. abstract. [PubMed] [Google Scholar]
  • 40.Saroea H.G. Common colds. Causes, potential cures, and treatment. Can Fam Physician. 1993;39:2215–2216. 2219–2220. [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 41.Pitkaranta A., Hayden F.G. Rhinoviruses: important respiratory pathogens. Ann Med. 1998;30:529–537. doi: 10.3109/07853899709002600. [DOI] [PubMed] [Google Scholar]
  • 42.Isaacson G. Sinusitis in childhood. Pediatr Clin North Am. 1996;436:1297. doi: 10.1016/s0031-3955(05)70520-4. [DOI] [PubMed] [Google Scholar]
  • 43.AAP Policy Statement: revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections—Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics. 2003;112:1442–1446. [PubMed] [Google Scholar]
  • 44.Centers for Disease Control and Prevention: The Advisory Committee on Immunization Practices national immunization program, 2004. Available at www.cdc.gov/vaccines/recs/acip/downloads/min-archive/min-june04.rtf. Accessed August 15, 2005.
  • 45.AAP Policy Statement: Recommendations for influenza immunization of children—Committee on Infectious Diseases. Pediatrics. 2004;113:1441–1447. doi: 10.1542/peds.113.5.1441. [DOI] [PubMed] [Google Scholar]
  • 46.World Health Organization: Communicable diseases. Available at www.searo.who.int/LinkFiles/ RC_54_WorkofWHO. pdf LinkFiles/ RC_54_WorkofWHO. pdf. Accessed August 15, 2005.

Acupuncture

  • 1.Zhu S., Wang N., Wang D. A clinical investigation on massage for prevention and treatment of recurrent respiratory tract infection in children. J Tradit Chin Med. 1998;18:285–291. [PubMed] [Google Scholar]
  • 2.Chen K., Li S., Shi Z. Two hundred and seventeen cases of winter diseases treated with acupoint stimulation in summer. J Tradit Chin Med. 2000;20:198–201. [PubMed] [Google Scholar]
  • 3.Hu J. Acupuncture treatment of common cold. J Tradit Chin Med. 2000;20:227–230. [PubMed] [Google Scholar]
  • 4.Xu J. Influence of acupuncture on human nasal mucociliary transport [in Chinese] Zhonghua Er Bi Yan Hou Ke Za Zhi. 1989;24:90–91. 127. [PubMed] [Google Scholar]
  • 5.Yu S., Cao J., Yu Z. Acupuncture treatment of chronic rhinitis in 75 cases. J Tradit Chin Med. 1993;13:103–105. [PubMed] [Google Scholar]
  • 6.Oskolkova M.K., Podgalo D.A., Briazgunov I.P. Acupuncture and electropuncture in the overall therapy of diseases in children [in Russian] Pediatriia. 1980:53–56. Mar abstract. [PubMed] [Google Scholar]
  • 7.Long X., Chang Q., Shou Q. Clinical observation on 46 cases of infantile repeated respiratory tract infection treated by mild-moxibustion over acupoints on back. J Tradit Chin Med. 2001;21:23–26. [PubMed] [Google Scholar]
  • 8.Davies A., Lewith G., Goddard J. The effect of acupuncture on nonallergic rhinitis: a controlled pilot study. Altern Ther Health Med. 1998;4:70–74. [PubMed] [Google Scholar]
  • 9.Yu P., Hao X., Zhao R. Pasting acupoints with Chinese herbs applying in infant acute bronchitis and effect on humoral immune substances [in Chinese] Zhen Ci Yan Jiu. 1992;17:110–112. abstract. [PubMed] [Google Scholar]
  • 10.Ng D.K., Chow P.Y., Ming S.P. A double-blind, randomized, placebo-controlled trial of acupuncture for the treatment of childhood persistent allergic rhinitis. Pediatrics. 2004;114:1242–1247. doi: 10.1542/peds.2004-0744. [DOI] [PubMed] [Google Scholar]
  • 11.Tan D. Treatment of fever due to exopathic wind-cold by rapid acupuncture. J Tradit Chin Med. 1992;12:267–271. [PubMed] [Google Scholar]
  • 12.Takeuchi H., Jawad M.S., Eccles R. The effects of nasal massage of the “yingxiang” acupuncture point on nasal airway resistance and sensation of nasal airflow in patients with nasal congestion associated with acute upper respiratory tract infection. Am J Rhinol. 1999;13:77–79. doi: 10.2500/105065899782106670. [DOI] [PubMed] [Google Scholar]
  • 13.Pothman R., Yeh H.L. The effects of treatment with antibiotics, laser and acupuncture upon chronic maxillary sinusitis in children. Am J Chin Med. 1982;10:55–58. doi: 10.1142/S0192415X82000099. [DOI] [PubMed] [Google Scholar]
  • 14.Loo M. Pediatric acupuncture. Elsevier; London: 2002. [Google Scholar]

Aromatherapy

  • 1.Keville K., Green M. Aromatherapy: a complete guide to the healing art. The Crossing Press; Berkeley, Calif: 1995. [Google Scholar]
  • 2.Buckle J. Clinical aromatherapy: essential oils in practice. ed 2. Churchill Livingstone; Edinburgh: 2003. [Google Scholar]
  • 3.Price S., Price L. Aromatherapy for health professionals. Churchill Livingstone; Edinburgh: 1995. [Google Scholar]
  • 4.Price S., Parr P.P. Aromatherapy for babies and children. Thorsons; San Francisco: 1996. [Google Scholar]
  • 5.Hasani A., Pavia D., Toms N. Effect of aromatics on lung mucociliary clearance in patients with chronic airways obstruction. J Altern Complement Med. 2003;9:243–249. doi: 10.1089/10755530360623356. [DOI] [PubMed] [Google Scholar]

Herbs—Chinese

  • 1.Neustaedter R: Personal communication, August 2005.

Herbs—Western

  • 1.Brinkeborn R.M., Shah D.V., Degenring F.H. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial. Phytomedicine. 1999;6:1–6. doi: 10.1016/S0944-7113(99)80027-0. [DOI] [PubMed] [Google Scholar]
  • 2.Barrett B., Vohmann M., Calabrese C. Echinacea for upper respiratory infection. J Fam Pract. 1999;48:628–635. [PubMed] [Google Scholar]
  • 3.Lindenmuth G.F., Lindenmuth E.B. The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind, placebo-controlled study. J Altern Complement Med. 2000;6:327–334. doi: 10.1089/10755530050120691. [DOI] [PubMed] [Google Scholar]
  • 4.Dorn M., Knick E., Lewith G. Placebo-controlled, double-blind study of Echinacea pallida radix in upper respiratory tract infections. Complement Ther Med. 1997;5:40–42. [Google Scholar]
  • 5.Henneicke-von Zepelin H., Hentschel C., Schnitker J. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo-controlled, multicentre study. Curr Med Res Opin. 1999;15:214–227. doi: 10.1185/03007999909114094. [DOI] [PubMed] [Google Scholar]
  • 6.Giles J.T., Palat C.T., III, Chien S.H. Evaluation of echinacea for treatment of the common cold. Pharmacother. 2000;20:690–697. doi: 10.1592/phco.20.7.690.35173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Melchart D., Linde K., Fischer P. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2. 2000 doi: 10.1002/14651858.CD000530. CD000530. [DOI] [PubMed] [Google Scholar]
  • 8.Schulten B., Bulitta M., Ballering-Bruhl B. Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trial. Arzneimittelforschung. 2001;51:563–568. doi: 10.1055/s-0031-1300080. [DOI] [PubMed] [Google Scholar]
  • 9.Goel V., Lovlin R., Barton R. Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther. 2004;29:75–83. doi: 10.1111/j.1365-2710.2003.00542.x. [DOI] [PubMed] [Google Scholar]
  • 10.Grimm W., Muller H.H. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med. 1999;106:138–143. doi: 10.1016/s0002-9343(98)00406-9. [DOI] [PubMed] [Google Scholar]
  • 11.Barrett B.P., Brown R.L., Locken K. Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002;137:939–946. doi: 10.7326/0003-4819-137-12-200212170-00006. [DOI] [PubMed] [Google Scholar]
  • 12.Yale S.H., Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2004;164:1237–1241. doi: 10.1001/archinte.164.11.1237. [DOI] [PubMed] [Google Scholar]
  • 13.Taylor J.A., Weber W., Standish L. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. J Am Med Assoc. 2003;290:2824–2830. doi: 10.1001/jama.290.21.2824. [DOI] [PubMed] [Google Scholar]
  • 14.Cohen H.A., Varsano I., Kahan E. Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study. Arch Pediatr Adolesc Med. 2004;158:217–221. doi: 10.1001/archpedi.158.3.217. [DOI] [PubMed] [Google Scholar]

Massage Therapy

  • 1.Boat T.F. Cystic fibrosis. In: Behrman R.E., Kliegman R., Jenson H.B., editors. Nelson textbook of pediatrics. ed 17. Saunders; Philadelphia: 2004. [Google Scholar]
  • 2.Shafer T.H., Wolfson M.R., Bhutani V.K. Respiratory muscle function, assessment and training. Phys Ther. 1983;61:1711–1723. doi: 10.1093/ptj/61.12.1711. [DOI] [PubMed] [Google Scholar]
  • 3.Warren A. Mobilization of the chest wall. Phys Ther. 1968;48:582–585. doi: 10.1093/ptj/48.6.582. [DOI] [PubMed] [Google Scholar]
  • 4.Field T., Henteleff T., Hernandez-Reif M. Children with asthma have improved pulmonary functions after massage therapy. J Pediatr. 1998;132:854–858. doi: 10.1016/s0022-3476(98)70317-8. [DOI] [PubMed] [Google Scholar]
  • 5.Hernandez-Reif M., Field T., Krasnegor J. Children with cystic fibrosis benefit from massage therapy. J Pediatr Psychol. 1999;24:175–181. doi: 10.1093/jpepsy/24.2.175. [DOI] [PubMed] [Google Scholar]
  • 6.Beeken J.E., Parks D., Cory J. The effectiveness of neuromuscular release massage therapy in five individuals with chronic obstructive lung disease. Clin Nurs Res. 1998;7:309–325. doi: 10.1177/105477389800700307. [DOI] [PubMed] [Google Scholar]
  • 7.Witt P., MacKinnon J. Psychological integration: a method to improve chest mobility of patients with chronic lung disease. Phys Ther. 1986;66:214–217. doi: 10.1093/ptj/66.2.214. [DOI] [PubMed] [Google Scholar]
  • 8.Fritz S. Mosby's fundamentals of therapeutic massage. ed 3. Mosby; St Louis: 2005. [Google Scholar]

Articles from Integrative Medicine for Children are provided here courtesy of Elsevier

RESOURCES